NCT06863025

Brief Summary

The goal of this study is to investigate new neuromodulation therapies for attention deficits following acquired brain injury. Brain damage can affect various domains, including motor and cognitive functions. However, cognitive deficits have many consequences on the functionality and independence of patients, and attention is an essential requirement for most of daily activities. After brain damage, cognitive rehabilitation is generally the first treatment option for attention deficits. Some studies have shown that cognitive rehabilitation is sometimes not very effective. For this reason, new therapies such as neuromodulation techniques are being investigated. Neurofeedback is a non-invasive neuromodulation therapy involving a type of computer-based training and learning, and some studies have shown that it is a promising tool to treat cognitive deficits in patients with brain injuries. In the present study, the investigators will evaluate the effects of neurofeedback as a therapy for attentional deficits after brain injury. Participants undergoing neurofeedback and cognitive therapy will be compared to participants only receiving cognitive therapy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

March 7, 2025

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

October 11, 2024

Last Update Submit

March 4, 2025

Conditions

Keywords

neurofeedbackbrain injuryattentional deficitsneuromodulationneurorehabilitation

Outcome Measures

Primary Outcomes (6)

  • Behavioral effectiveness of NF on attention measures - CCPT

    The Conners Continuous Performance Test (CCPT ) is a computer administered test designed to assess problems with attention. It presents 360 stimuli trials (i.e., individual letters) on the screen, with 1, 2, or 4 seconds intervals between the presentation. The 360 trials are divided into 18 blocks of 20 trials each and participants instructed to press the spacebar or the appropriate key on the mouse for any letter that appears, except the letter "X." The CCPT takes 14 minutes to administer. Through the various measures of the CCPT we can measure different aspects of attentional deficits such as processing speed, sustained and selective attention, inhibition, vigilance, inattention.

    The CCPT will be assessed during the pre-treatment assessment (within three weeks before the start of the treatment) and the post-treatment assessment (within 3 weeks of the end of the treatment)

  • Behavioral effectiveness of NF on attention measures - Color Trail Test

    The Color Trail Test evaluates processing speed, selective attention, sequencing, mental flexibility, visual search, and motor function. It has been used for detecting cognitive impairment in early stages and a wide variety of neurological processes and disorders. In Part A of the test, the subject is presented with a sheet with numbers from 1 to 25 placed inside circles and distributed randomly across an A4-sized sheet. The task involves connecting the numbers consecutively and in ascending order as quickly as possible. In Part B of the test, the 25 numbers are duplicated inside circles of two different colors, a sequence of pink and another of yellow. In this part, the subject must connect the consecutive numbers while alternating the color of the circles.

    The Color Trail Test will be assessed during the pre-treatment assessment (within three weeks before the start of the treatment) and the post-treatment assessment (within 3 weeks of the end of the treatment)

  • Behavioral effectiveness of NF on attention measures - Digit and Spatial Span

    The Spatial Span test relies on visuospatial working memory. It is a variation of the Corsi block tapping task a widely used tool in clinical neuropsychology to assess non-verbal memory deficits. The original task involves irregularly arranged mounted wooden blocks, and the examiner taps out a sequence that the patient is required to mimic. The digit span test is a very short test that evaluates a person's cognitive status that initially was part of Wechsler's Intelligence Scale. It consists of telling the participant a series of numbers and ask him to repeat them back to you in the same order you say them. The first series are composed of three numbers, the next series four numbers, then five etc. The series are repeated until one incorrect answer is observed. Both the digit and spatial span tests are frequently used in hospitals and physicians' offices in order for a clinician to quickly evaluate whether a person's cognitive abilities are normal or impaired

    The Digit and Spatial Span tests will be assessed during the pre-treatment assessment (within three weeks before the start of the treatment) and the post-treatment assessment (within 3 weeks of the end of the treatment)

  • Behavioral effectiveness of NF on attention measures - D2-R

    The online d2-R is the computerized version of the d2 Test of Attention - Revised. The test measures the ability to concentrate and sustain attention. It consists of picking out target symbols, from among similar symbols, under pressure of time. The participant is asked to search for and mark certain target symbols (ie., the letter "d" with two dashes). The test itself consists of 14 screens in succession, each having 60 symbols laid out in six rows of ten. All instances of "d" with two dashes are to be marked. The instruction is to work quickly, without making mistakes.

    The D2-R test will be assessed during the pre-treatment assessment (within three weeks before the start of the treatment) and the post-treatment assessment (within 3 weeks of the end of the treatment)

  • electrophysiological effectiveness of NF - EEG power and connectivity

    EEG analyses are based on the recording of EEG signal, which is the sum of neuronal activity, mainly post-synaptic, represented on a time axis. Based on EEG we will be able to perform analyses on qEEG, connectivity between regions. We will use BrainVision system for EEG recording of 15 minutes of resting state.

    The EEG resting state will be recorded during the pre-treatment assessment (within three weeks before the start of the treatment) and the post-treatment assessment (within 3 weeks of the end of the treatment)

  • electrophysiological effectiveness of NF - P300 ERP

    The P300 is a component of an event-related potential (ERP), which is a measurable brain response to a specific stimulus. It typically occurs around 300 milliseconds after the presentation of a stimulus that is unexpected, infrequent, or relevant. It is often used in cognitive neuroscience to study attention and decision-making processes. It is detected using EEG and often uses tasks like the "oddball paradigm," where subjects are asked to detect infrequent target stimuli among frequent non-targets, to elicit the P300 response. P300 will be assessed with an auditory oddball paradigm built using Eprime and Brain Vision EEG system.

    The P300 will be assessed during the pre-treatment assessment (within three weeks before the start of the treatment) and the post-treatment assessment (within 3 weeks of the end of the treatment)

Secondary Outcomes (4)

  • Motivation of NF training compared to standard cognitive rehabilitation

    The IMI questionnaire will be provided to participants post-intervention (within 3 weeks of the end of the treatment)

  • Transfer to daily life and perceived effectiveness - PGIC

    The PGIC questionnaire will be provided to participants post-intervention (within 3 weeks of the end of the treatment)

  • Transfer to daily life and perceived effectiveness - Moss

    The Moss attentional questionnaire will be provided to participants post-intervention (within 3 weeks of the end of the treatment)

  • Transfer to daily life and perceived effectiveness - GAS

    The GAS questionnaire will be provided to participants post-intervention (within 3 weeks of the end of the treatment)

Study Arms (2)

Neurofeedback

EXPERIMENTAL

This group will receive 12 sessions of neurofeedback (20 minutes each session) targeting beta and theta. The neurofeedback protocol will aim at increasing frequencies between 16-25 and decreasing 4-7 Hz

Behavioral: Neurofeedback training

Control

ACTIVE COMPARATOR

This group will receive 12 sessions of standard practice cognitive therapy (20 minutes each session) targeting attentional deficits.

Behavioral: Standard cognitive therapy

Interventions

Neurofeedback (NF) or electroencephalographic feedback (EEG) training refers to a type of computerized cognitive training that changes EEG patterns through operant conditioning. NF is a computerized rehabilitation technique but also a non-invasive neuromodulation approach, as it alters brain activity by delivering a stimulus. It is well-established for the treatment of conditions such as anxiety and ADHD. During NF rehabilitative training, the subject is provided with real-time EEG feedback, usually with a visual or auditory stimulus, with the aim of normalizing brain oscillations. Rehabilitation through NF training generally targets EEG frequencies that are affected and underlie the observed behavioral deficit (e.g., attentional dysfunctions).

Neurofeedback

This is the control intervention and it involves standard practice cognitive therapy in neurorehabilitation. Neuropsychologists and other clinicians test and train the patients' cognitive specific aspect (in this case, attention) with some validated tools and/or games

Control

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old
  • ABI resulting from TBI, stroke, hypoxia and other etiologies
  • attentional deficits that are among the objectives of neurorehabilitation as established by the clinical team (scores falling in the 90% percentiles on the Conner's Continuous Performance - CCPT, on the Digit and Spatial Span Tasks and Color Trail test)
  • good cognitive condition (ie., scores of ≥23 in the Mini Mental State Examination
  • MMSE or ≥75 in the Galveston Orientation \& Amnesia Test - GOAT)

You may not qualify if:

  • previous report of psychiatric and/or neurologic disorders
  • contraindication to computerized activities
  • blindness or severe visual impairments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Irenea Neurorhb Sl

Valencia, Province de Valence, 46001, Spain

Location

Servicio de Neurorrehabilitación y Daño Cerebral de los Hospitales NISA

Valencia, Spain, 46011, Spain

Location

Related Links

MeSH Terms

Conditions

Brain InjuriesCognition Disorders

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
data will be coded and anonymised before performing the analyses on the outcome measures
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two groups: 1)experimental will receive treatment (NF), 2) control will receive standard cognitive therapy rehabilitation. groups will be matched for numbers of treatment received
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

October 11, 2024

First Posted

March 7, 2025

Study Start

October 1, 2024

Primary Completion

June 30, 2025

Study Completion

October 1, 2025

Last Updated

March 7, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Outcome and demographical/clinical data will not be made openly available as it is sensitive data and cannot be shared on open access unrestricted platforms. This is for legal reasons due to the fact that data might allow patient's identity to be revealed. Behavioural and raw EEG data (without any demographical and clinical information) might be shared with other scientists privately on platforms such as ResearchGate upon reasonable requests.

Locations